Hepatocellular carcinoma is a form of cancer that starts out in the liver. As far as cancers that begin in the liver, it’s common, but it’s still important to differentiate it from cancers that spread to the liver. Read more about this cancer here.

The National Cancer Institute has been looking into monoclonal antibodies– identical antibodies that are exact clones from of unique parent cell– that could potentially treat this form of cancer. They’re researching it in mouse models right now. Monoclonal antibodies would let them treat the cancer with more precision and fewer side effects. It’s also less invasive, and could help both detect and kill cancer cells that involve GPC3 over expression. This is good news for patients who suffer from a variety of other cancers as well, like melanoma, thyroid cancer, lung squamous cell carcinoma, Wilms tumor, neuroblastoma, hepatoblastoma, and testicular germ-cell tumors

Read all about it at bioportfolio.com.